AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
Article Link
Collect
Submit Manuscript
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Editorial | Open Access

The spring of China's national policy in clinical cell (somatic cell) therapy for neurorestoration

Brain Hospital, First Affiliated Hospital of Henan Medical University, Xinxiang, 453100, Henan, China
Department of Neurorestoratology, Taian Central Hospital, Taian, 271000, Shandong, China
Show Author Information

References

【1】
【1】
 
 
Journal of Neurorestoratology

{{item.num}}

Comments on this article

Go to comment

< Back to all reports

Review Status: {{reviewData.commendedNum}} Commended , {{reviewData.revisionRequiredNum}} Revision Required , {{reviewData.notCommendedNum}} Not Commended Under Peer Review

Review Comment

Close
Close
Cite this article:
Huang H. The spring of China's national policy in clinical cell (somatic cell) therapy for neurorestoration. Journal of Neurorestoratology, 2026, 14(1). https://doi.org/10.1016/j.jnrt.2026.100267

222

Views

0

Crossref

0

Web of Science

0

Scopus

Received: 10 November 2025
Revised: 24 November 2025
Accepted: 01 December 2025
Published: 01 February 2026
© 2026 The Author.

This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).